TETRADENTATE MACROCYCLIC METAL COMPLEXES
945
planar geometry while the ruthenium(III) and iridium (III) com-
plexes were found with octahedral geometry. The mass spectra
support the proposed structure of complexes by elemental anal-
yses. Different parameters, i.e., ꢁ, B and β were calculated
on the basis of absorption spectra, and the values suggest the
metal-ligand covalent bonding. The antifungal and antibacterial
screening of the compounds indicates that the Ru(III) complex
is highly active while the other metal complexes show moderate
activity in comparison of the free ligand
REFERENCES
1. (a) Kimura, E. Roles of zinc(II) ion in zinc enzymes. Pure Appl. Chem.,
1993, 65(3), 355–359.
(b) Shukla, D., Gupta, L.K., and Chandra, S. Spectroscopic studies on
chromium(III), manganese(II), cobalt(II), nickel(II) and copper(II) com-
plexes with hexadentate nitrogen-sulfur donor [N(2)S(4)] macrocyclic lig-
and. Spectrochim. Acta A 2008, 71(3), 746–750.
2. Chandra, S., and Pundir, M. Spectroscopic characterization of
chromium(III), manganese(II) and nickel(II) complexes with a nitrogen
donor tetradentate, 12-membered azamacrocyclic ligand. Spectrochim. Acta
A 2008, 69(1), 1–7.
3. Chandra, S., and Gautam, A. EPR, IR and electronic spectral studies on
Ni(II) and Cu(II) complexes with N-donor tetradentate [N4] macrocyclic
ligand Spectrochim. Acta A 2008, 70(5), 1001–1005.
4. Kimra, E., Shinoya, M., and Hoshino, A. A model for catalytically active
zinc(II) ion in liver alcohol dehydrogenase: a novel “hydride transfer” reac-
tion catalyzed by zinc(II)-macrocyclic polyamine complexes J. Am. Chem.
Soc., 1992, 114(26), 10134–10137.
5. Chandra, S., and Sharma, S. Synthesis and spectral studies of transi-
tion metal complexes with 1,5:11,15- dimetheno- 2,4,10,12-tetramethyl-
[1,5,9,13] tetraaza hexadeca-1, 3, 5, 6, 10, 11, 13, 15, 16,20-
decene a sixteen-membered tetradentate macrocyclic ligand. Trans. Met.
Chem., 2007, 32(2),150–154.
6. Chandra, S., and Gupta, L.K. Electronic, EPR, magnetic and mass spec-
tral studies of mono and homo-binuclear Co(II) and Cu(II) complexes
with a novel macrocyclic ligand. Spectrochim. Acta A 2005, 62(4, 5),
1102–1106.
7. Chandra, S., and Gupta, L.K. Mass, EPR, IR and electronic spectroscopic
studies on newly synthesized macrocyclic ligand and its transition metal
complexes. Spectrochim. Acta A 2005, 62(4,5), 1125–1130.
8. Burger, K., Illes, J., and Gyuresik, B. Metal ion coordination of macro-
molecular bioligands: formation of zinc(II) complex of hyaluronic acid.
Carbohydr. Res., 2001, 332(2), 197–207.
9. Eremenko, I.L., Nefedov, S.E., and Sidorov, A. A. Bi- and mononuclear
nickel(II) trimethylacetate complexes with pyridine bases as ligands. Inorg.
Chem., 1999, 38(17), 3764–3773.
10. Milovic, N.M., Dutca, L.M., and Kostic, N.M. Combined use of plat-
inum(II) complexes and palladium(II) complexes for selective cleavage
of peptides and proteins. Inorg. Chem., 2003, 42(13), 4036.
11. Tercero, J.M., Matilla, A., and Sanjuan, M.A. Synthesis, characterization,
solution equilibria and DNA binding of some mixed-ligand palladium(II)
complexes. Thermodynamic models for carboplatin drug and analogous
compounds. Inorg. Chim. Acta., 2003, 342(2), 77–87.
FIG. 5. Graphical representation of antibacterial activities of ligand (L) and
its complexes.
The activities were compared with the activity of the standard
fungicide Captan.
The antibacterial activity of the ligand and its complexes were
determined by disc diffusion method.[37,38] The compounds
were dissolved in DMSO to get the test solutions. 20 mL of
the nutrient agar medium was poured on each petriplate, and af-
ter it 0.5 mL of test bacterial broth was spread over the medium.
25 µL of test solution was applied on the 10 mm diameter sterile
disc. After evaporating the solvent, the discs were placed at the
center of inoculated petriplates and sealed by para film. After
keeping the petriplates at 2◦C for 2 h, they were incubated at
26 1◦C for 24 h. The diameters of the inhibition zones were
measured in millimeters (Figure 5).
It has been found that the activity of the ligand was al-
ways less pronounced than those of its complexes, demonstrat-
ing that complexation with metals enhance the anti-pathogenic
activity of the ligand. The antifungal and the antibacterial
screening data of the free ligand and its metal indicate that all
the complexes are more active as compared to the free ligand.
The ligand and its complexes show fungal and bacterial growth
inhibition in the following order.
Ru(III) > Pd(II) > Pt(II) > Ir(III) > ligand(L)
Ru(III) > Pt(II) > Pd(II) > Ir(III) > ligand(L)
12. Tripathi, L., Kumar, P., and Singhai, A.K. Role of chelates in treatment of
cancer. Indian J. Cancer 2007, 44(2), 62–71.
13. Sandercock, J., Parmar, M.K., Torri, V., and Quian, W. First-line treatment
for advanced ovarian cancer: paclitaxel, platinum and the evidence. Br. J.
Cancer, 2002, 87(8), 815–824.
14. Roh, J.L., Moon, B.J., Kim, J.S., Lee, J.H., Nam, S.Y., Lee, B.J., and
Kim, S.Y. Use of 18F-fluorodeoxyglucose positron emission tomography
in patients with rare head and neck cancers. Clin Exp Otorhinolaryngol.,
2008, 1(2), 103–109.
CONCLUSION
On the basis of IR, mass and UV spectral studies the pal-
ladium(II) and platinum(II) complexes were found with square